ArticleFrontiers in immunology2023

Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.

Lesang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.